| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18496 R78607 |
Xu, 2024 | Stillbirth (NOS) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: prescription or medical files | 2.29 [1.19;4.43] | 41/501 24/501 | 65 | 501 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18513 R78656 |
Zafeiri, 2022 | Stillbirth | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy | 1.52 [1.30;1.77] | 275/23,979 803/106,752 | 1,078 | 23,979 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18546 R78823 |
Rebordosa, 2009 | Stillbirth (dead fetus delivered spontaneously after the 28th gestational week (>196 days)) | during pregnancy (anytime or not specified) | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy | 0.90 [0.69;1.19] | 98/- 111/- | 209 | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18623 R79152 |
Pastore, 1999 | Stillbirths (fetal deaths at 20 weeks' gestation or later) and infant deaths within 24 h of birth | 2nd trimester | case control | unexposed (general population or NOS) | Adjustment: Yes Matched Paracetamol use: maternal ITW/questionnaires after pregnancy | 0.90 [0.80;1.00] | 95/219 237/470 | 332 | 219 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 4 studies | 1.21 [0.84;1.73] | 1,684 | 24,699 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded